ADVERTISEMENT

Europe backs RSV vaccine for older adults

Deepa Varma   |   Medical News   |   28 April 2023
ADVERTISEMENT

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of the vaccine Arexvy (recombinant, adjuvanted), for use against lower respiratory tract disease caused by respiratory syncytial virus (RSV) in adults aged 60 and older.

Arexvy was evaluated through the EMA's accelerated assessment mechanism ...

          

November Challenge

Ends in 1d 15h
left
right

Topic Challenges

left
right